Literature DB >> 31062608

Long non-coding RNA UCA1 exerts growth modulation by miR-15a in human thyroid cancer TPC-1 cells.

Dandan Li1, Shuai Hao1, Jing Zhang1.   

Abstract

Thyroid cancer is widely diagnosed as malignancy in endocrine system. This study attempted to validate UCA1 possessed modulatory function on cell proliferation and epithelial mesenchymal transition (EMT) in human thyroid cancer cell line TPC-1. Ectopic expression of UCA1 was induced in TPC-1 cells by transfection. CCK-8 assays were employed to value cell viability. Cell apoptosis analysis was conducted through flow cytometry. We found that overexpressed UCA1 strongly promoted cell proliferation. However, the knockdown of UCA1 suppressed cell proliferation and induced obvious cell apoptosis. Besides, cell EMT was promoted by overexpressed UCA1 and was inhibited by the knockdown of UCA1. Further study revealed that miR-15a level in TPC-1 cells was suppressed by overexpressed UCA1. Simultaneous overexpression of UCA1 and miR-15a partly alleviated UCA1-induced growth, identifying that miR-15a was a possible target of UCA1. At last, the Hippo and JNK signal pathways were activated by overexpressed UCA1 but were then weakened by the adding of miR-15a. In conclusion, our study revealed UCA1/miR-15a axis implicated in thyroid cancer cells EMT, exposing a novel mechanism of thyroid cancer progression.

Entities:  

Keywords:  EMT; UCA1; miR-15a; proliferation; thyroid cancer

Mesh:

Substances:

Year:  2019        PMID: 31062608     DOI: 10.1080/21691401.2019.1606007

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  6 in total

1.  Ursolic acid ameliorates Nthy-ori 3-1 cells injury induced by IL-1β through limiting MALAT1/miR-206/PTGS1 ceRNA network and NF-κB signaling pathway.

Authors:  Lunpan Mou; Liyan Liao; Yaping Zhang; Desong Ming; Jianjia Jiang
Journal:  Psychopharmacology (Berl)       Date:  2021-01-16       Impact factor: 4.530

2.  Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.

Authors:  Wei Wang; Wentao Hu; Ya Wang; Yong An; Lei Song; Panfeng Shang; Zhongjin Yue
Journal:  Mol Cancer       Date:  2020-01-29       Impact factor: 27.401

3.  Down-regulation of lncRNA UCA1 enhances radiosensitivity in prostate cancer by suppressing EIF4G1 expression via sponging miR-331-3p.

Authors:  Minhua Hu; Jincheng Yang
Journal:  Cancer Cell Int       Date:  2020-09-11       Impact factor: 5.722

Review 4.  Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer.

Authors:  Mengwei Wang; Tianwei Xu; Wenyan Feng; Junxia Liu; Zhaoxia Wang
Journal:  Onco Targets Ther       Date:  2021-04-07       Impact factor: 4.147

Review 5.  E-cadherin on epithelial-mesenchymal transition in thyroid cancer.

Authors:  Xiaoyu Zhu; Xiaoping Wang; Yifei Gong; Junlin Deng
Journal:  Cancer Cell Int       Date:  2021-12-20       Impact factor: 5.722

Review 6.  The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression.

Authors:  Chao Tu; Kexin Yang; Lu Wan; Jieyu He; Lin Qi; Wanchun Wang; Qiong Lu; Zhihong Li
Journal:  Cell Prolif       Date:  2020-08-10       Impact factor: 6.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.